Researchers uncovered distinctive gut microbial patterns and hundreds of altered fecal metabolites in people with esophageal cancer, with lipid metabolism standing out as a key signature. Study: Fecal metabolomic and microbiome profiling reveals lipid metabolic dysregulation in esophageal cancer. Image credit: PBXStudio/Shutterstock.com A recent Scientific Reports study investigated associations between gut microbiota, fecal metabolic alterations, and esophageal cancer using advanced metabolomic and 16S ribosomal RNA (rRNA) gene sequencing approaches. Esophageal cancer: subtypes, risk factors, and clinical outlook Esophageal cancer is an aggressive malignancy and a leading cause of global cancer mortality. The two predominant histological subtypes, squamous cell carcinoma (SCC) and adenocarcinoma (AC), display pronounced geographic variation; SCC is particularly prevalent in China, while AC predominates in Western countries. Small cell carcinoma remains rare but clinically significant. Risk factors include tobacco and alcohol use (primarily for SCC), chronic gastroesophageal reflux disease and Barrett’s esophagus (for AC), as well as dietary deficiencies, obesity, and genetic predisposition. The etiology is thus multifactorial, reflecting complex interactions among environmental, dietary, genetic, and gastroesophageal influences. Early-stage esophageal cancer is often asymptomatic or presents with vague symptoms, leading to diagnosis at locally advanced or metastatic stages in 70–80% of patients. Despite advances in treatment, outcomes remain...